Study of Pemetrexed for Second-Line Pancreas Cancer

NCT00864513 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped At interim analysis the study did not meet the response criteria to continue

Conditions

Pancreas Cancer

Interventions

DRUG: pemetrexed

Sponsor

Georgetown University

Collaborators

[object Object]